Incidence of Retinal Vasculitis With or Without Retinal Vascular Occlusion Among Eyes Treated With Approved Anti-Vascular Endothelial Growth Factor Agents in Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema

06/12/2023
22/08/2024
EU PAS number:
EUPAS107730
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Prot CR45271 faricimab v2, Published Output-1_signed_20231206_Redacted.pdf

English (659.02 KB - PDF) View document
Updated protocol

Prot CR45271 faricimab v3, Published Output-1_Redacted.pdf

First published: 16/08/2024
English (706.13 KB - PDF) View document
Study results
Study report
Other information